• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Tandem Diabetes Care appoints Dr. Jordan Pinsker as its medical director

March 1, 2021 By Sean Whooley

Tandem Diabetes CareTandem Diabetes Care (NSDQ:TNDM) announced today that it appointed Dr. Jordan Pinsker as its VP & medical director.

The San Diego-based insulin delivery technology developer’s appointment of Pinsker will be made effective on April 26, 2021, according to a news release.

Pinsker joins Tandem from Sansum Diabetes Research Institute in Santa Barbara, Calif., where he served as Director of Artificial Pancreas Technology starting in 2018. While with Sansum, he served as a lead investigator in a number of clinical trials for automated insulin delivery systems, including Tandem’s Basal-IQ and Control-IQ technology.

He also served as Chief of Pediatric Endocrinology at Tripler Army Medical Center in Hawaii, along with a role as a physician in the U.S. Army in both active duty and the California Army National Guard for more than 20 years.

“Dr. Pinsker brings extensive knowledge in patient care, diabetes epidemiology, and physician practice efficiency, in addition to sharing our passion for improving the lives of people with diabetes,” Tandem Diabetes Care president & CEO John Sheridan said in the release. “We welcome him to Tandem’s management team as we work together to lead in insulin therapy management using our automated insulin delivery technology and flagship pumps.”

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured Tagged With: Personnel, Personnel Moves, Tandem Diabetes Care

IN CASE YOU MISSED IT

  • Medtronic to separate Diabetes business unit
  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS